Use of lenalidomide in the management of relapsed or refractory multiple myeloma: expert recommendations in Korea

Multiple myeloma (MM) is the third most common hematologic malignancy in Korea. Historically, the incidence of MM in Korea has been lower than that in Western populations, although there is growing evidence that the incidence of MM in Asian populations, including Korea, is increasing rapidly. Despit...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Blood Res
Main Authors: Kim, Hyo Jung, Yoon, Sung-Soo, Eom, Hyeon Seok, Kim, Kihyun, Kim, Jin Seok, Lee, Je-Jung, Bang, Soo-Mee, Min, Chang-Ki, Park, Joon Seong, Lee, Jae-Hoon
Formato: Artigo
Idioma:Inglês
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2015
Assuntos:
Review Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4377347/
https://ncbi.nlm.nih.gov/pubmed/25830125
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5045/br.2015.50.1.7
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares